Adherence to Current COPD Guidelines in Turkey

Basit Öğe Kaydı
dc.authoridDeniz, Sami/0000-0002-8328-295X
dc.authorid/0000-0001-6209-7758
dc.contributor.authorTuran, Onur
dc.contributor.authorEmre, Julide Celdir
dc.contributor.authorDeniz, Sami
dc.contributor.authorBaysak, Aysegul
dc.contributor.authorTuran, Pakize Ayse
dc.contributor.authorMirici, Arzu
dc.date.accessioned2025-01-27T20:47:52Z
dc.date.available2025-01-27T20:47:52Z
dc.date.issued2016
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractIntroduction-objective: Despite the availability of national and international guidelines, chronic obstructive pulmonary diseases (COPD) treatment is not always prescribed according to these recommendations. We aimed to see if COPD patients in Turkey have been treated appropriately according to COPD guidelines. Methods: This is a cross-sectional study carried out in six different chest diseases clinics. The COPD outpatients were categorized by spirometry classification (SC) and the combined classification (CC) of COPD. The treatment protocols were evaluated to check whether they were suitable for both classifications. Results: Overall, 307 patients were included in the study. Of the treatment protocols, 40.4% were suitable for both classifications: 30.9% for CC and 20.8% for SC. A total of 51.8% of the patients were reported to be using an unsuitable therapy for SC and 38.4% for CC. Ninety-eight per cent of the unsuitable treatment was overtreatment. Fifty-eight per cent of the patients were using LABA+LAMA+ICS. Improper ICS usage was identified in 97.1% in CC, 93.1% in SC. The cost savings of all patients in one year would be 17,099$ with an appropriate treatment protocol following COPD guidelines. Conclusion: The most common type of inappropriate COPD treatments is overtreatment, generally with ICS. As treatment protocols following COPD guidelines change over time, there is still a low rate of adherence by clinicians in their clinical practice to guideline recommendations. Awareness of these guidelines by pulmonary specialists should be improved.
dc.identifier.doi10.1517/14656566.2016.1115482
dc.identifier.endpage158
dc.identifier.issn1465-6566
dc.identifier.issn1744-7666
dc.identifier.issue2
dc.identifier.pmid26629809
dc.identifier.scopus2-s2.0-84957433584
dc.identifier.scopusqualityQ2
dc.identifier.startpage153
dc.identifier.urihttps://doi.org/10.1517/14656566.2016.1115482
dc.identifier.urihttps://hdl.handle.net/20.500.12428/25071
dc.identifier.volume17
dc.identifier.wosWOS:000370166200002
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofExpert Opinion on Pharmacotherapy
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectAdherence
dc.subjectCOPD
dc.subjectguidelines
dc.subjectovertreatment
dc.titleAdherence to Current COPD Guidelines in Turkey
dc.typeReview Article

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu